A Phase II Trial of Olanzapine (ZYPREXA) for the Prevention of Delayed Emesis in Cancer Patients Recieving Chemotherapy


Grants and Contracts Details


OBJECTIVES 1.1 Examine the efficacy and tolerability of olanzapine (Zyprexa) therapy in combination with dexamethasone for the prevention of chemotherapy induced acute and delayed emesis and nausea in chemotherapy naIve patents receiving moderately emetogenic (doxorubicin, irinotecan, cyclophosphamide) or highly emetogenic (cisplatin) chemotherapy. 1.2 To determine the feasibility of measures of efficacy to assess delayed nausea and vomiting.
Effective start/end date1/31/0312/31/04


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.